Referencias bibliográficas

    1. Barbosa-Cortés, L., Martínez-Vieyra, X., Mejía-Aranguré, J. M., López-Alarcón, M., Martin-Trejo, J., Delgadillo-Portillo, S., Guzmán-Castro, B., Delgadillo-Portillo, J., Atilano-Miguel, S., Rodríguez-Cruz, M., Maldonado-Hernández, J., Añoveros-Barrera, A., Solís-Labastida, K. A., Espinoza-Hernández, L., Nuñez-Villegas, N. N., Jiménez-Hernández, E., Bautista- Martínez, B. A., Juárez-Moya, A., Hernández-Piñón, Z., & Pérez-Casillas, R. X. (2023). Pilot study on the effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on body composition in children with acute lymphoblastic leukemia: randomized clinical trial. Clinical Nutrition, 42(9), 1759–1769. https://doi.org/10.1016/j.clnu.2023.06.022
    2. Cagigas, M. L., Rajakumar, G., Skarratt, K., Hayward, R., Pelaia, T., Ardjmand, A., Vaughan, L., Fontana, L., & Fuller, S. (2023). PB1796: ADMINISTRATION OF A KETOGENIC DIET FOR CHEMOTHERAPY PROTECTION IN ACUTE LEUKEMIA PATIENTS: IS IT FEASIBLE, SAFE, AND VALUABLE? PRELIMINARY RESULTS OF THE RANDOMIZED CONTROLLED TRIAL LEU-KETO STUDY. HemaSphere, 7(S3), e189423f. https://doi.org/10.1097/01.HS9.0000974040.18942.3f
    3. Cao, F., Zhang, H., Xu, B., & Li, C. (2024). Genetic association between gut microbiota and the risk of Guillain-Barré syndrome. Journal of Affective Disorders, 357, 171–178. https://doi.org/10.1016/j.jad.2024.05.011
    4. Caserotti, P., Aagaard, P., Buttrup Larsen, J., & Puggaard, L. (2008). Explosive heavy‐resistance training in old and very old adults: changes in rapid muscle force, strength and power. Scandinavian Journal of Medicine & Science in Sports, 18(6), 773–782. https://doi.org/10.1111/j.1600-0838.2007.00732.x
    5. Cheung, K., Askari, S., & Allen, M. D. (2023). A novel approach to mitigate muscle atrophy in Guillain-Barre syndrome. Advanced Neurology, 2(2), 280. https://doi.org/10.36922/an.280
    6. Collings, T. J., Lima, Y. L., Dutaillis, B., & Bourne, M. N. (2024). Concurrent validity and test–retest reliability of VALD ForceDecks’ strength, balance, and movement assessment tests. Journal of Science and Medicine in Sport, 27(8), 572–580. https://doi.org/10.1016/j.jsams.2024.04.014
    7. Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., Schneider, S. M., Sieber, C. C., Topinkova, E., Vandewoude, M., Visser, M., Zamboni, M., Bautmans, I., Baeyens, J.-P., Cesari, M., … Schols, J. (2019). Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing, 48(1), 16–31. https://doi.org/10.1093/ageing/afy169
    8. de Sousa, C. N. S., da Silva Leite, C. M. G., da Silva Medeiros, I., Vasconcelos, L. C., Cabral, L. M., Patrocínio, C. F. V., Patrocínio, M. L. V., Mouaffak, F., Kebir, O., Macedo, D., Patrocínio, M. C. A., & Vasconcelos, S. M. M. (2019). Alpha-lipoic acid in the treatment of psychiatric and neurological disorders: a systematic review. Metabolic Brain Disease, 34(1), 39–52. https://doi.org/10.1007/s11011-018-0344-x
    9. DiNardo, C. D., & Wei, A. H. (2020). How I treat acute myeloid leukemia in the era of new drugs. Blood, 135(2), 85–96. https://doi.org/10.1182/blood.2019001239
    10. Döhner, H., Weisdorf, D. J., & Bloomfield, C. D. (2015). Acute Myeloid Leukemia. New England Journal of Medicine, 373(12), 1136–1152. https://doi.org/10.1056/NEJMra1406184
    11. Entezari, M., Tayari, A., Paskeh, M. D. A., Kheirabad, S. K., Naeemi, S., Taheriazam, A., Dehghani, H., Salimimoghadam, S., Hashemi, M., Mirzaei, S., & Samarghandian, S. (2024). Curcumin in treatment of hematological cancers: Promises and challenges. Journal of Traditional and Complementary Medicine, 14(2), 121–134. https://doi.org/10.1016/j.jtcme.2023.10.004
    12. Estey, E., & Döhner, H. (2006). Acute myeloid leukaemia. The Lancet, 368(9550), 1894–1907. https://doi.org/10.1016/S0140-6736(06)69780-8
    13. Ferrucci, L., de Cabo, R., Knuth, N. D., & Studenski, S. (2012). Of Greek Heroes, Wiggling Worms, Mighty Mice, and Old Body Builders. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 67A(1), 13–16. https://doi.org/10.1093/gerona/glr046
    14. Gao, Y., Zhang, H.-L., Xin, M., Wang, D., Zheng, N., Wang, S., Xu, J., Wang, Y., Zhu, J., & Feng, J. (2018). Serum Folate Correlates with Severity of Guillain-Barré Syndrome and Predicts Disease Progression. BioMed Research International, 2018, 1–5. https://doi.org/10.1155/2018/5703279
    15. Gomez-Candela, C., Canales Albendea, M. A., Palma Milla, S., de Paz Arias, R., Díaz Gomez, J., Rodrigguez-Durán, D., Villarino-Sanz, M., Arribas-Hortiguela, L., & Burgos Peláez, R. (2012). Nutritional intervention in oncohematological patient. Nutrición Hospitalaria, 27(3), 669–680. https://doi.org/10.3305/nh.2012.27.3.5863
    16. Hasan, I., Saif‐Ur‐Rahman, K., Hayat, S., Papri, N., Jahan, I., Azam, R., Ara, G., & Islam, Z. (2020). <scp>Guillain‐Barré</scp> syndrome associated with <scp>SARS‐CoV</scp> ‐2 infection: A systematic review and individual participant data meta‐analysis. Journal of the Peripheral Nervous System, 25(4), 335–343. https://doi.org/10.1111/jns.12419
    17. Hopker, J., Myers, S., Jobson, S. A., Bruce, W., & Passfield, L. (2010). Validity and Reliability of the Wattbike Cycle Ergometer. International Journal of Sports Medicine, 31(10), 731–736. https://doi.org/10.1055/s-0030-1261968
    18. Janssen, J. B. E., Leow, T. Y. S., Herbschleb, K. H., Gijtenbeek, J. M. M., Boers-Sonderen, M. J., Gerritsen, W. R., & Westdorp, H. (2021). Immune Checkpoint Inhibitor–related Guillain-Barré Syndrome: A Case Series and Review of the Literature. Journal of Immunotherapy, 44(7), 276–282. https://doi.org/10.1097/CJI.0000000000000364
    19. Kyriazoglou, A., Liontos, M., Papadopoulos, C., Bilali, A., Kostouros, E., Pagoni, S., Doumas, K., Dimopoulos, M. A., & Bamias, A. (2019). Guillain-Barré Syndrome Related to Nivolumab: Case Report of a Patient With Urothelial Cancer and Reviewof the Literature. Clinical Genitourinary Cancer, 17(2), e360–e364. https://doi.org/10.1016/j.clgc.2018.11.022
    20. Levison, L. S., Thomsen, R. W., Sindrup, S. H., & Andersen, H. (2022). Association Between Incident Cancer and Guillain-Barré Syndrome Development. Neurology, 98(15). https://doi.org/10.1212/WNL.0000000000200015
    21. Liu, R. D. K. S., Chinapaw, M. J. M., Huijgens, P. C., & Mechelen, W. van. (2009). Physical exercise interventions in haematological cancer patients, feasible to conduct but effectiveness to be established: A systematic literature review. Cancer Treatment Reviews, 35(2), 185–192. https://doi.org/10.1016/j.ctrv.2008.09.008
    22. Matsuo, K., Ishiguro, T., Najama, T., Shimizu, Y., Kobayashi, Y., & Mutou, M. (2019). Nivolumab-induced Myocarditis Successfully Treated with Corticosteroid Therapy: A Case Report and Review of the Literature. Internal Medicine, 58(16), 2367–2372. https://doi.org/10.2169/internalmedicine.2596-18
    23. Montoye, A. H. K., Vondrasek, J. D., & Hancock, J. B. (2020). Validity and Reliability of the VO2 Master Pro for Oxygen Consumption and Ventilation Assessment. International Journal of Exercise Science, 13(4), 1382–1401.
    24. Mouchel, P. L., Bérard, E., Tavitian, S., Gadaud, N., Vergez, F., Rieu, J. B., Luquet, I., Sarry, A., Huguet, F., Largeaud, L., Delabesse, E., Huynh, A., Bertoli, S., & Récher, C. (2023). Vitamin C and D supplementation in acute myeloid leukemia. Blood Advances, 7(22), 6886–6897. https://doi.org/10.1182/bloodadvances.2023010559
    25. Musleh, M., & Alhussien, Q. (2024). A chronic myeloid leukemia present with an unusual relapse in central nervous system: A case report. Clinical Case Reports, 12(4). https://doi.org/10.1002/ccr3.8671
    26. Nguyen, T. P., & Taylor, R. S. (2024). Guillain-Barre Syndrome. StatPearls Publishing.
    27. Picou, F., Debeissat, C., Bourgeais, J., Gallay, N., Ferrié, E., Foucault, A., Ravalet, N., Maciejewski, A., Vallet, N., Ducrocq, E., Haddaoui, L., Domenech, J., Hérault, O., & Gyan, E. (2018). n-3 Polyunsaturated fatty acids induce acute myeloid leukemia cell death associated with mitochondrial glycolytic switch and Nrf2 pathway activation. Pharmacological Research, 136, 45–55. https://doi.org/10.1016/j.phrs.2018.08.015
    28. Polončič, P., Novak, P., Puzić Ravnjak, N., & Majdič, N. (2021). The associations between nutritional and functional status during recovery from Guillain–Barré syndrome: a retrospective study. International Journal of Rehabilitation Research, 44(1), 57–64. https://doi.org/10.1097/MRR.0000000000000437
    29. Reyna-Figueroa, J., Barrón-Calvillo, E., García-Parra, C., Galindo-Delgado, P., Contreras-Ochoa, C., Lagunas-Martínez, A., Campos-Romero, F. H., Silva-Estrada, J. A., & Limón-Rojas, A. E. (2019). Probiotic Supplementation Decreases Chemotherapy-induced Gastrointestinal Side Effects in Patients With Acute Leukemia. Journal of Pediatric Hematology/Oncology, 41(6), 468–472. https://doi.org/10.1097/MPH.0000000000001497
    30. Rohilla, R., Kakkar, A. K., Divyashree, K., Mohindra, R., & Suri, V. (2023). Recombinant protein subunit COVID‐19 vaccine‐induced Guillain‐Barré Syndrome in an adolescent: A case report. British Journal of Clinical Pharmacology, 89(2), 556–560. https://doi.org/10.1111/bcp.15466
    31. Romero, F. B., Hernández-López, A., Martínez, J. J. A., Gómez-Garrido, M., & Lamas-Oliveira, C. (2015). Enteral Nutrition in Neurological Patients. In Diet and Nutrition in Critical Care (pp. 1591–1598). Springer New York. https://doi.org/10.1007/978-1-4614-7836-2_56
    32. Roubenoff, R. A., Borel, C. O., & Hanley, D. F. (1992). Hypermetabolism and Hypercatabolism in Guillain‐Barré Syndrome. Journal of Parenteral and Enteral Nutrition, 16(5), 464–472. https://doi.org/10.1177/0148607192016005464
    33. Shah, N., Shrivastava, M., Kumar, S., & Nagi, R. S. (2022). Supervised, individualised exercise reduces fatigue and improves strength and quality of life more than unsupervised home exercise in people with chronic Guillain-Barré syndrome: a randomised trial. Journal of Physiotherapy, 68(2), 123–129. https://doi.org/10.1016/j.jphys.2022.03.007
    34. Tadmor, T., Melamed, G., Alapi, H., Gazit, S., Patalon, T., & Rokach, L. (2024). Vitamin D supplement for patients with early-stage chronic lymphocytic leukemia is associated with a longer time to first treatment. Blood Advances, 8(14), 3840–3846. https://doi.org/10.1182/bloodadvances.2023011458
    35. Thapa, B., Khalid, S., Vakili, R., Ui, J., & Misbah, S. (2018). Nivolumab-Associated Guillain–Barre Syndrome in a Patient With Non–Small-Cell Lung Cancer. American Journal of Therapeutics, 25(6), e761–e763. https://doi.org/10.1097/MJT.0000000000000771
    36. van Haren, I. E. P. M., Staal, J. B., Potting, C. M., Atsma, F., Hoogeboom, T. J., Blijlevens, N. M. A., & Nijhuis-van der Sanden, M. W. G. (2018). Physical exercise prior to hematopoietic stem cell transplantation: A feasibility study. Physiotherapy Theory and Practice, 34(10), 747–756. https://doi.org/10.1080/09593985.2018.1423655
    37. Yeung, S. S. Y., Reijnierse, E. M., Trappenburg, M. C., Hogrel, J.-Y., McPhee, J. S., Piasecki, M., Sipila, S., Salpakoski, A., Butler-Browne, G., Pääsuke, M., Gapeyeva, H., Narici, M. V., Meskers, C. G. M., & Maier, A. B. (2018). Handgrip Strength Cannot Be Assumed a Proxy for Overall Muscle Strength. Journal of the American Medical Directors Association, 19(8), 703–709. https://doi.org/10.1016/j.jamda.2018.04.019